nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—ABCB1—kidney cancer	0.216	1	CbGaD
Doxazosin—ORM1—Erlotinib—kidney cancer	0.0829	0.17	CbGbCtD
Doxazosin—ABCB1—Temsirolimus—kidney cancer	0.0487	0.0996	CbGbCtD
Doxazosin—KCNH2—Sunitinib—kidney cancer	0.0481	0.0985	CbGbCtD
Doxazosin—CYP2D6—Temsirolimus—kidney cancer	0.0459	0.0938	CbGbCtD
Doxazosin—ABCB1—Pazopanib—kidney cancer	0.0256	0.0523	CbGbCtD
Doxazosin—CYP2D6—Pazopanib—kidney cancer	0.0241	0.0493	CbGbCtD
Doxazosin—ABCB1—Dactinomycin—kidney cancer	0.0234	0.0478	CbGbCtD
Doxazosin—ABCB1—Gemcitabine—kidney cancer	0.0185	0.0378	CbGbCtD
Doxazosin—CYP2C19—Sorafenib—kidney cancer	0.0184	0.0376	CbGbCtD
Doxazosin—ABCB1—Erlotinib—kidney cancer	0.0182	0.0373	CbGbCtD
Doxazosin—CYP2D6—Erlotinib—kidney cancer	0.0172	0.0352	CbGbCtD
Doxazosin—ABCB1—Paclitaxel—kidney cancer	0.0167	0.0342	CbGbCtD
Doxazosin—ABCB1—Sorafenib—kidney cancer	0.0148	0.0303	CbGbCtD
Doxazosin—ABCB1—Vinblastine—kidney cancer	0.0146	0.03	CbGbCtD
Doxazosin—ABCB1—Vincristine—kidney cancer	0.0144	0.0295	CbGbCtD
Doxazosin—CYP2D6—Sorafenib—kidney cancer	0.014	0.0286	CbGbCtD
Doxazosin—CYP2D6—Vinblastine—kidney cancer	0.0138	0.0282	CbGbCtD
Doxazosin—ABCB1—Sunitinib—kidney cancer	0.012	0.0246	CbGbCtD
Doxazosin—ABCB1—Doxorubicin—kidney cancer	0.009	0.0184	CbGbCtD
Doxazosin—CYP2D6—Doxorubicin—kidney cancer	0.00848	0.0173	CbGbCtD
Doxazosin—Donepezil—ACHE—kidney cancer	0.00286	0.593	CrCbGaD
Doxazosin—CYP2C19—urine—kidney cancer	0.00216	0.149	CbGeAlD
Doxazosin—KCNH6—nephron tubule—kidney cancer	0.0018	0.124	CbGeAlD
Doxazosin—KCNH6—renal system—kidney cancer	0.00164	0.113	CbGeAlD
Doxazosin—KCNH6—kidney—kidney cancer	0.00158	0.109	CbGeAlD
Doxazosin—CYP2D6—urine—kidney cancer	0.00126	0.0865	CbGeAlD
Doxazosin—ADRA1B—renal system—kidney cancer	0.000928	0.064	CbGeAlD
Doxazosin—ADRA1B—kidney—kidney cancer	0.000897	0.0618	CbGeAlD
Doxazosin—Prazosin—CYP1A1—kidney cancer	0.00085	0.176	CrCbGaD
Doxazosin—Terazosin—ABCB1—kidney cancer	0.000659	0.137	CrCbGaD
Doxazosin—ADRA1A—renal system—kidney cancer	0.000522	0.0359	CbGeAlD
Doxazosin—KCNH2—renal system—kidney cancer	0.000504	0.0347	CbGeAlD
Doxazosin—Prazosin—ABCB1—kidney cancer	0.000452	0.0937	CrCbGaD
Doxazosin—KCNH2—cardiac atrium—kidney cancer	0.000451	0.0311	CbGeAlD
Doxazosin—ADRA2A—cortex of kidney—kidney cancer	0.000373	0.0257	CbGeAlD
Doxazosin—ADRA2A—gonad—kidney cancer	0.000356	0.0245	CbGeAlD
Doxazosin—ADRA2A—cardiac atrium—kidney cancer	0.000355	0.0245	CbGeAlD
Doxazosin—CYP2D6—renal system—kidney cancer	0.000307	0.0212	CbGeAlD
Doxazosin—CYP2D6—kidney—kidney cancer	0.000297	0.0205	CbGeAlD
Doxazosin—ABCB1—nephron tubule—kidney cancer	0.000243	0.0167	CbGeAlD
Doxazosin—ABCB1—renal system—kidney cancer	0.000221	0.0152	CbGeAlD
Doxazosin—ABCB1—kidney—kidney cancer	0.000214	0.0147	CbGeAlD
Doxazosin—ABCB1—cortex of kidney—kidney cancer	0.000208	0.0143	CbGeAlD
Doxazosin—ABCB1—gonad—kidney cancer	0.000198	0.0137	CbGeAlD
Doxazosin—Pruritus—Sunitinib—kidney cancer	0.000117	0.000447	CcSEcCtD
Doxazosin—Arthralgia—Paclitaxel—kidney cancer	0.000116	0.000443	CcSEcCtD
Doxazosin—Chest pain—Paclitaxel—kidney cancer	0.000116	0.000443	CcSEcCtD
Doxazosin—Myalgia—Paclitaxel—kidney cancer	0.000116	0.000443	CcSEcCtD
Doxazosin—Anxiety—Paclitaxel—kidney cancer	0.000116	0.000441	CcSEcCtD
Doxazosin—Face oedema—Doxorubicin—kidney cancer	0.000116	0.000441	CcSEcCtD
Doxazosin—Decreased appetite—Gemcitabine—kidney cancer	0.000115	0.000441	CcSEcCtD
Doxazosin—Hypersensitivity—Dactinomycin—kidney cancer	0.000115	0.000441	CcSEcCtD
Doxazosin—Chills—Capecitabine—kidney cancer	0.000115	0.00044	CcSEcCtD
Doxazosin—Arrhythmia—Capecitabine—kidney cancer	0.000115	0.000438	CcSEcCtD
Doxazosin—Discomfort—Paclitaxel—kidney cancer	0.000115	0.000438	CcSEcCtD
Doxazosin—Fatigue—Gemcitabine—kidney cancer	0.000115	0.000437	CcSEcCtD
Doxazosin—Gastrointestinal pain—Vincristine—kidney cancer	0.000115	0.000437	CcSEcCtD
Doxazosin—Dizziness—Sorafenib—kidney cancer	0.000114	0.000434	CcSEcCtD
Doxazosin—Constipation—Gemcitabine—kidney cancer	0.000114	0.000434	CcSEcCtD
Doxazosin—Pain—Gemcitabine—kidney cancer	0.000114	0.000434	CcSEcCtD
Doxazosin—Nausea—Erlotinib—kidney cancer	0.000114	0.000434	CcSEcCtD
Doxazosin—Alopecia—Capecitabine—kidney cancer	0.000114	0.000433	CcSEcCtD
Doxazosin—Dry mouth—Paclitaxel—kidney cancer	0.000113	0.000433	CcSEcCtD
Doxazosin—Mood swings—Doxorubicin—kidney cancer	0.000113	0.000433	CcSEcCtD
Doxazosin—Diarrhoea—Sunitinib—kidney cancer	0.000113	0.000432	CcSEcCtD
Doxazosin—Ataxia—Doxorubicin—kidney cancer	0.000113	0.00043	CcSEcCtD
Doxazosin—Mental disorder—Capecitabine—kidney cancer	0.000113	0.00043	CcSEcCtD
Doxazosin—Asthenia—Dactinomycin—kidney cancer	0.000112	0.000429	CcSEcCtD
Doxazosin—Confusional state—Paclitaxel—kidney cancer	0.000112	0.000428	CcSEcCtD
Doxazosin—Malnutrition—Capecitabine—kidney cancer	0.000112	0.000427	CcSEcCtD
Doxazosin—Dehydration—Doxorubicin—kidney cancer	0.000111	0.000425	CcSEcCtD
Doxazosin—Oedema—Paclitaxel—kidney cancer	0.000111	0.000425	CcSEcCtD
Doxazosin—Abdominal pain—Vincristine—kidney cancer	0.000111	0.000423	CcSEcCtD
Doxazosin—Body temperature increased—Vincristine—kidney cancer	0.000111	0.000423	CcSEcCtD
Doxazosin—Liver function test abnormal—Doxorubicin—kidney cancer	0.000111	0.000422	CcSEcCtD
Doxazosin—Infection—Paclitaxel—kidney cancer	0.000111	0.000422	CcSEcCtD
Doxazosin—Flatulence—Capecitabine—kidney cancer	0.00011	0.000421	CcSEcCtD
Doxazosin—Dry skin—Doxorubicin—kidney cancer	0.00011	0.000419	CcSEcCtD
Doxazosin—Dysgeusia—Capecitabine—kidney cancer	0.00011	0.000418	CcSEcCtD
Doxazosin—Dizziness—Sunitinib—kidney cancer	0.000109	0.000418	CcSEcCtD
Doxazosin—Feeling abnormal—Gemcitabine—kidney cancer	0.000109	0.000418	CcSEcCtD
Doxazosin—Shock—Paclitaxel—kidney cancer	0.000109	0.000418	CcSEcCtD
Doxazosin—Vomiting—Sorafenib—kidney cancer	0.000109	0.000418	CcSEcCtD
Doxazosin—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000109	0.000417	CcSEcCtD
Doxazosin—Hypokalaemia—Doxorubicin—kidney cancer	0.000109	0.000416	CcSEcCtD
Doxazosin—Thrombocytopenia—Paclitaxel—kidney cancer	0.000109	0.000416	CcSEcCtD
Doxazosin—Tachycardia—Paclitaxel—kidney cancer	0.000109	0.000414	CcSEcCtD
Doxazosin—Rash—Sorafenib—kidney cancer	0.000108	0.000414	CcSEcCtD
Doxazosin—Dermatitis—Sorafenib—kidney cancer	0.000108	0.000414	CcSEcCtD
Doxazosin—Back pain—Capecitabine—kidney cancer	0.000108	0.000413	CcSEcCtD
Doxazosin—Skin disorder—Paclitaxel—kidney cancer	0.000108	0.000412	CcSEcCtD
Doxazosin—Headache—Sorafenib—kidney cancer	0.000108	0.000412	CcSEcCtD
Doxazosin—Muscle spasms—Capecitabine—kidney cancer	0.000108	0.000411	CcSEcCtD
Doxazosin—Hyperhidrosis—Paclitaxel—kidney cancer	0.000108	0.000411	CcSEcCtD
Doxazosin—Diarrhoea—Dactinomycin—kidney cancer	0.000107	0.000409	CcSEcCtD
Doxazosin—Anorexia—Paclitaxel—kidney cancer	0.000106	0.000405	CcSEcCtD
Doxazosin—Muscular weakness—Doxorubicin—kidney cancer	0.000106	0.000403	CcSEcCtD
Doxazosin—Vision blurred—Capecitabine—kidney cancer	0.000105	0.000402	CcSEcCtD
Doxazosin—Vomiting—Sunitinib—kidney cancer	0.000105	0.000402	CcSEcCtD
Doxazosin—Body temperature increased—Gemcitabine—kidney cancer	0.000105	0.000401	CcSEcCtD
Doxazosin—Tremor—Capecitabine—kidney cancer	0.000105	0.0004	CcSEcCtD
Doxazosin—Rash—Sunitinib—kidney cancer	0.000104	0.000399	CcSEcCtD
Doxazosin—Dermatitis—Sunitinib—kidney cancer	0.000104	0.000398	CcSEcCtD
Doxazosin—Abdominal distension—Doxorubicin—kidney cancer	0.000104	0.000398	CcSEcCtD
Doxazosin—Hypotension—Paclitaxel—kidney cancer	0.000104	0.000397	CcSEcCtD
Doxazosin—Ill-defined disorder—Capecitabine—kidney cancer	0.000104	0.000396	CcSEcCtD
Doxazosin—Headache—Sunitinib—kidney cancer	0.000104	0.000396	CcSEcCtD
Doxazosin—Hypersensitivity—Vincristine—kidney cancer	0.000103	0.000394	CcSEcCtD
Doxazosin—Nausea—Sorafenib—kidney cancer	0.000102	0.00039	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000101	0.000387	CcSEcCtD
Doxazosin—Malaise—Capecitabine—kidney cancer	0.000101	0.000385	CcSEcCtD
Doxazosin—Angina pectoris—Doxorubicin—kidney cancer	0.000101	0.000385	CcSEcCtD
Doxazosin—Insomnia—Paclitaxel—kidney cancer	0.000101	0.000384	CcSEcCtD
Doxazosin—Vertigo—Capecitabine—kidney cancer	0.0001	0.000384	CcSEcCtD
Doxazosin—Asthenia—Vincristine—kidney cancer	0.0001	0.000384	CcSEcCtD
Doxazosin—Syncope—Capecitabine—kidney cancer	0.0001	0.000383	CcSEcCtD
Doxazosin—Leukopenia—Capecitabine—kidney cancer	0.0001	0.000382	CcSEcCtD
Doxazosin—Paraesthesia—Paclitaxel—kidney cancer	9.99e-05	0.000381	CcSEcCtD
Doxazosin—Vomiting—Dactinomycin—kidney cancer	9.97e-05	0.00038	CcSEcCtD
Doxazosin—Bronchitis—Doxorubicin—kidney cancer	9.95e-05	0.00038	CcSEcCtD
Doxazosin—Dyspnoea—Paclitaxel—kidney cancer	9.92e-05	0.000379	CcSEcCtD
Doxazosin—Somnolence—Paclitaxel—kidney cancer	9.89e-05	0.000377	CcSEcCtD
Doxazosin—Palpitations—Capecitabine—kidney cancer	9.88e-05	0.000377	CcSEcCtD
Doxazosin—Rash—Dactinomycin—kidney cancer	9.88e-05	0.000377	CcSEcCtD
Doxazosin—Nausea—Sunitinib—kidney cancer	9.84e-05	0.000375	CcSEcCtD
Doxazosin—Loss of consciousness—Capecitabine—kidney cancer	9.83e-05	0.000375	CcSEcCtD
Doxazosin—Dyspepsia—Paclitaxel—kidney cancer	9.79e-05	0.000374	CcSEcCtD
Doxazosin—Cough—Capecitabine—kidney cancer	9.76e-05	0.000373	CcSEcCtD
Doxazosin—Dysuria—Doxorubicin—kidney cancer	9.68e-05	0.000369	CcSEcCtD
Doxazosin—Neutropenia—Doxorubicin—kidney cancer	9.68e-05	0.000369	CcSEcCtD
Doxazosin—Decreased appetite—Paclitaxel—kidney cancer	9.67e-05	0.000369	CcSEcCtD
Doxazosin—Hypertension—Capecitabine—kidney cancer	9.66e-05	0.000369	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Doxorubicin—kidney cancer	9.62e-05	0.000367	CcSEcCtD
Doxazosin—Fatigue—Paclitaxel—kidney cancer	9.59e-05	0.000366	CcSEcCtD
Doxazosin—Diarrhoea—Vincristine—kidney cancer	9.58e-05	0.000366	CcSEcCtD
Doxazosin—Pollakiuria—Doxorubicin—kidney cancer	9.56e-05	0.000365	CcSEcCtD
Doxazosin—Asthenia—Gemcitabine—kidney cancer	9.53e-05	0.000364	CcSEcCtD
Doxazosin—Myalgia—Capecitabine—kidney cancer	9.52e-05	0.000364	CcSEcCtD
Doxazosin—Chest pain—Capecitabine—kidney cancer	9.52e-05	0.000364	CcSEcCtD
Doxazosin—Arthralgia—Capecitabine—kidney cancer	9.52e-05	0.000364	CcSEcCtD
Doxazosin—Pain—Paclitaxel—kidney cancer	9.51e-05	0.000363	CcSEcCtD
Doxazosin—Constipation—Paclitaxel—kidney cancer	9.51e-05	0.000363	CcSEcCtD
Doxazosin—Anxiety—Capecitabine—kidney cancer	9.49e-05	0.000362	CcSEcCtD
Doxazosin—Photosensitivity reaction—Doxorubicin—kidney cancer	9.44e-05	0.000361	CcSEcCtD
Doxazosin—Weight increased—Doxorubicin—kidney cancer	9.42e-05	0.000359	CcSEcCtD
Doxazosin—Discomfort—Capecitabine—kidney cancer	9.41e-05	0.000359	CcSEcCtD
Doxazosin—Pruritus—Gemcitabine—kidney cancer	9.4e-05	0.000359	CcSEcCtD
Doxazosin—Weight decreased—Doxorubicin—kidney cancer	9.36e-05	0.000357	CcSEcCtD
Doxazosin—Hyperglycaemia—Doxorubicin—kidney cancer	9.33e-05	0.000356	CcSEcCtD
Doxazosin—Dry mouth—Capecitabine—kidney cancer	9.31e-05	0.000356	CcSEcCtD
Doxazosin—Nausea—Dactinomycin—kidney cancer	9.31e-05	0.000355	CcSEcCtD
Doxazosin—Pneumonia—Doxorubicin—kidney cancer	9.28e-05	0.000354	CcSEcCtD
Doxazosin—Dizziness—Vincristine—kidney cancer	9.26e-05	0.000354	CcSEcCtD
Doxazosin—Drowsiness—Doxorubicin—kidney cancer	9.23e-05	0.000352	CcSEcCtD
Doxazosin—Confusional state—Capecitabine—kidney cancer	9.2e-05	0.000351	CcSEcCtD
Doxazosin—Feeling abnormal—Paclitaxel—kidney cancer	9.17e-05	0.00035	CcSEcCtD
Doxazosin—Oedema—Capecitabine—kidney cancer	9.13e-05	0.000348	CcSEcCtD
Doxazosin—Gastrointestinal pain—Paclitaxel—kidney cancer	9.1e-05	0.000347	CcSEcCtD
Doxazosin—Diarrhoea—Gemcitabine—kidney cancer	9.09e-05	0.000347	CcSEcCtD
Doxazosin—Infection—Capecitabine—kidney cancer	9.07e-05	0.000346	CcSEcCtD
Doxazosin—Jaundice—Doxorubicin—kidney cancer	8.99e-05	0.000343	CcSEcCtD
Doxazosin—Shock—Capecitabine—kidney cancer	8.98e-05	0.000343	CcSEcCtD
Doxazosin—Conjunctivitis—Doxorubicin—kidney cancer	8.97e-05	0.000342	CcSEcCtD
Doxazosin—Urinary tract infection—Doxorubicin—kidney cancer	8.97e-05	0.000342	CcSEcCtD
Doxazosin—Thrombocytopenia—Capecitabine—kidney cancer	8.94e-05	0.000341	CcSEcCtD
Doxazosin—Tachycardia—Capecitabine—kidney cancer	8.91e-05	0.00034	CcSEcCtD
Doxazosin—Vomiting—Vincristine—kidney cancer	8.9e-05	0.00034	CcSEcCtD
Doxazosin—Skin disorder—Capecitabine—kidney cancer	8.87e-05	0.000338	CcSEcCtD
Doxazosin—Sweating—Doxorubicin—kidney cancer	8.84e-05	0.000338	CcSEcCtD
Doxazosin—Urticaria—Paclitaxel—kidney cancer	8.84e-05	0.000337	CcSEcCtD
Doxazosin—Rash—Vincristine—kidney cancer	8.83e-05	0.000337	CcSEcCtD
Doxazosin—Hyperhidrosis—Capecitabine—kidney cancer	8.82e-05	0.000337	CcSEcCtD
Doxazosin—Dermatitis—Vincristine—kidney cancer	8.82e-05	0.000337	CcSEcCtD
Doxazosin—Haematuria—Doxorubicin—kidney cancer	8.8e-05	0.000336	CcSEcCtD
Doxazosin—Body temperature increased—Paclitaxel—kidney cancer	8.79e-05	0.000336	CcSEcCtD
Doxazosin—Abdominal pain—Paclitaxel—kidney cancer	8.79e-05	0.000336	CcSEcCtD
Doxazosin—Headache—Vincristine—kidney cancer	8.77e-05	0.000335	CcSEcCtD
Doxazosin—Epistaxis—Doxorubicin—kidney cancer	8.7e-05	0.000332	CcSEcCtD
Doxazosin—Anorexia—Capecitabine—kidney cancer	8.7e-05	0.000332	CcSEcCtD
Doxazosin—Sinusitis—Doxorubicin—kidney cancer	8.66e-05	0.00033	CcSEcCtD
Doxazosin—Hypotension—Capecitabine—kidney cancer	8.53e-05	0.000326	CcSEcCtD
Doxazosin—Vomiting—Gemcitabine—kidney cancer	8.45e-05	0.000322	CcSEcCtD
Doxazosin—Bradycardia—Doxorubicin—kidney cancer	8.43e-05	0.000322	CcSEcCtD
Doxazosin—Rash—Gemcitabine—kidney cancer	8.38e-05	0.00032	CcSEcCtD
Doxazosin—Dermatitis—Gemcitabine—kidney cancer	8.37e-05	0.000319	CcSEcCtD
Doxazosin—Headache—Gemcitabine—kidney cancer	8.32e-05	0.000318	CcSEcCtD
Doxazosin—Nausea—Vincristine—kidney cancer	8.32e-05	0.000318	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Capecitabine—kidney cancer	8.32e-05	0.000317	CcSEcCtD
Doxazosin—Rhinitis—Doxorubicin—kidney cancer	8.3e-05	0.000317	CcSEcCtD
Doxazosin—Hepatitis—Doxorubicin—kidney cancer	8.28e-05	0.000316	CcSEcCtD
Doxazosin—Insomnia—Capecitabine—kidney cancer	8.26e-05	0.000315	CcSEcCtD
Doxazosin—Hypoaesthesia—Doxorubicin—kidney cancer	8.24e-05	0.000315	CcSEcCtD
Doxazosin—Pharyngitis—Doxorubicin—kidney cancer	8.22e-05	0.000314	CcSEcCtD
Doxazosin—Paraesthesia—Capecitabine—kidney cancer	8.2e-05	0.000313	CcSEcCtD
Doxazosin—Hypersensitivity—Paclitaxel—kidney cancer	8.2e-05	0.000313	CcSEcCtD
Doxazosin—Dyspnoea—Capecitabine—kidney cancer	8.14e-05	0.000311	CcSEcCtD
Doxazosin—Dyspepsia—Capecitabine—kidney cancer	8.04e-05	0.000307	CcSEcCtD
Doxazosin—Visual impairment—Doxorubicin—kidney cancer	7.98e-05	0.000305	CcSEcCtD
Doxazosin—Asthenia—Paclitaxel—kidney cancer	7.98e-05	0.000305	CcSEcCtD
Doxazosin—Decreased appetite—Capecitabine—kidney cancer	7.94e-05	0.000303	CcSEcCtD
Doxazosin—Nausea—Gemcitabine—kidney cancer	7.89e-05	0.000301	CcSEcCtD
Doxazosin—Fatigue—Capecitabine—kidney cancer	7.87e-05	0.0003	CcSEcCtD
Doxazosin—Pruritus—Paclitaxel—kidney cancer	7.87e-05	0.0003	CcSEcCtD
Doxazosin—Pain—Capecitabine—kidney cancer	7.81e-05	0.000298	CcSEcCtD
Doxazosin—Constipation—Capecitabine—kidney cancer	7.81e-05	0.000298	CcSEcCtD
Doxazosin—Eye disorder—Doxorubicin—kidney cancer	7.74e-05	0.000295	CcSEcCtD
Doxazosin—Tinnitus—Doxorubicin—kidney cancer	7.72e-05	0.000295	CcSEcCtD
Doxazosin—Flushing—Doxorubicin—kidney cancer	7.69e-05	0.000293	CcSEcCtD
Doxazosin—Diarrhoea—Paclitaxel—kidney cancer	7.61e-05	0.000291	CcSEcCtD
Doxazosin—Feeling abnormal—Capecitabine—kidney cancer	7.52e-05	0.000287	CcSEcCtD
Doxazosin—Gastrointestinal pain—Capecitabine—kidney cancer	7.46e-05	0.000285	CcSEcCtD
Doxazosin—Chills—Doxorubicin—kidney cancer	7.43e-05	0.000284	CcSEcCtD
Doxazosin—Arrhythmia—Doxorubicin—kidney cancer	7.4e-05	0.000282	CcSEcCtD
Doxazosin—Dizziness—Paclitaxel—kidney cancer	7.36e-05	0.000281	CcSEcCtD
Doxazosin—Alopecia—Doxorubicin—kidney cancer	7.32e-05	0.000279	CcSEcCtD
Doxazosin—Mental disorder—Doxorubicin—kidney cancer	7.26e-05	0.000277	CcSEcCtD
Doxazosin—Urticaria—Capecitabine—kidney cancer	7.25e-05	0.000277	CcSEcCtD
Doxazosin—Abdominal pain—Capecitabine—kidney cancer	7.22e-05	0.000275	CcSEcCtD
Doxazosin—Body temperature increased—Capecitabine—kidney cancer	7.22e-05	0.000275	CcSEcCtD
Doxazosin—Malnutrition—Doxorubicin—kidney cancer	7.21e-05	0.000275	CcSEcCtD
Doxazosin—Flatulence—Doxorubicin—kidney cancer	7.1e-05	0.000271	CcSEcCtD
Doxazosin—Tension—Doxorubicin—kidney cancer	7.08e-05	0.00027	CcSEcCtD
Doxazosin—Vomiting—Paclitaxel—kidney cancer	7.07e-05	0.00027	CcSEcCtD
Doxazosin—Dysgeusia—Doxorubicin—kidney cancer	7.06e-05	0.00027	CcSEcCtD
Doxazosin—Rash—Paclitaxel—kidney cancer	7.01e-05	0.000268	CcSEcCtD
Doxazosin—Dermatitis—Paclitaxel—kidney cancer	7.01e-05	0.000267	CcSEcCtD
Doxazosin—Nervousness—Doxorubicin—kidney cancer	7e-05	0.000267	CcSEcCtD
Doxazosin—Back pain—Doxorubicin—kidney cancer	6.97e-05	0.000266	CcSEcCtD
Doxazosin—Headache—Paclitaxel—kidney cancer	6.97e-05	0.000266	CcSEcCtD
Doxazosin—Muscle spasms—Doxorubicin—kidney cancer	6.93e-05	0.000265	CcSEcCtD
Doxazosin—Vision blurred—Doxorubicin—kidney cancer	6.79e-05	0.000259	CcSEcCtD
Doxazosin—Hypersensitivity—Capecitabine—kidney cancer	6.73e-05	0.000257	CcSEcCtD
Doxazosin—Ill-defined disorder—Doxorubicin—kidney cancer	6.69e-05	0.000255	CcSEcCtD
Doxazosin—Agitation—Doxorubicin—kidney cancer	6.63e-05	0.000253	CcSEcCtD
Doxazosin—Nausea—Paclitaxel—kidney cancer	6.61e-05	0.000252	CcSEcCtD
Doxazosin—Asthenia—Capecitabine—kidney cancer	6.55e-05	0.00025	CcSEcCtD
Doxazosin—Malaise—Doxorubicin—kidney cancer	6.5e-05	0.000248	CcSEcCtD
Doxazosin—Vertigo—Doxorubicin—kidney cancer	6.48e-05	0.000247	CcSEcCtD
Doxazosin—Syncope—Doxorubicin—kidney cancer	6.47e-05	0.000247	CcSEcCtD
Doxazosin—Pruritus—Capecitabine—kidney cancer	6.46e-05	0.000247	CcSEcCtD
Doxazosin—Leukopenia—Doxorubicin—kidney cancer	6.45e-05	0.000246	CcSEcCtD
Doxazosin—Palpitations—Doxorubicin—kidney cancer	6.37e-05	0.000243	CcSEcCtD
Doxazosin—Loss of consciousness—Doxorubicin—kidney cancer	6.34e-05	0.000242	CcSEcCtD
Doxazosin—Cough—Doxorubicin—kidney cancer	6.29e-05	0.00024	CcSEcCtD
Doxazosin—Convulsion—Doxorubicin—kidney cancer	6.25e-05	0.000238	CcSEcCtD
Doxazosin—Diarrhoea—Capecitabine—kidney cancer	6.25e-05	0.000238	CcSEcCtD
Doxazosin—Hypertension—Doxorubicin—kidney cancer	6.22e-05	0.000238	CcSEcCtD
Doxazosin—Chest pain—Doxorubicin—kidney cancer	6.14e-05	0.000234	CcSEcCtD
Doxazosin—Arthralgia—Doxorubicin—kidney cancer	6.14e-05	0.000234	CcSEcCtD
Doxazosin—Myalgia—Doxorubicin—kidney cancer	6.14e-05	0.000234	CcSEcCtD
Doxazosin—Anxiety—Doxorubicin—kidney cancer	6.12e-05	0.000234	CcSEcCtD
Doxazosin—Discomfort—Doxorubicin—kidney cancer	6.06e-05	0.000232	CcSEcCtD
Doxazosin—Dizziness—Capecitabine—kidney cancer	6.04e-05	0.00023	CcSEcCtD
Doxazosin—Dry mouth—Doxorubicin—kidney cancer	6e-05	0.000229	CcSEcCtD
Doxazosin—Confusional state—Doxorubicin—kidney cancer	5.93e-05	0.000226	CcSEcCtD
Doxazosin—Oedema—Doxorubicin—kidney cancer	5.88e-05	0.000225	CcSEcCtD
Doxazosin—Infection—Doxorubicin—kidney cancer	5.85e-05	0.000223	CcSEcCtD
Doxazosin—Vomiting—Capecitabine—kidney cancer	5.8e-05	0.000222	CcSEcCtD
Doxazosin—Shock—Doxorubicin—kidney cancer	5.79e-05	0.000221	CcSEcCtD
Doxazosin—Thrombocytopenia—Doxorubicin—kidney cancer	5.76e-05	0.00022	CcSEcCtD
Doxazosin—Rash—Capecitabine—kidney cancer	5.76e-05	0.00022	CcSEcCtD
Doxazosin—Dermatitis—Capecitabine—kidney cancer	5.75e-05	0.00022	CcSEcCtD
Doxazosin—Tachycardia—Doxorubicin—kidney cancer	5.74e-05	0.000219	CcSEcCtD
Doxazosin—Headache—Capecitabine—kidney cancer	5.72e-05	0.000218	CcSEcCtD
Doxazosin—Skin disorder—Doxorubicin—kidney cancer	5.72e-05	0.000218	CcSEcCtD
Doxazosin—Hyperhidrosis—Doxorubicin—kidney cancer	5.69e-05	0.000217	CcSEcCtD
Doxazosin—Anorexia—Doxorubicin—kidney cancer	5.61e-05	0.000214	CcSEcCtD
Doxazosin—Hypotension—Doxorubicin—kidney cancer	5.5e-05	0.00021	CcSEcCtD
Doxazosin—Nausea—Capecitabine—kidney cancer	5.42e-05	0.000207	CcSEcCtD
Doxazosin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.36e-05	0.000205	CcSEcCtD
Doxazosin—Insomnia—Doxorubicin—kidney cancer	5.32e-05	0.000203	CcSEcCtD
Doxazosin—Paraesthesia—Doxorubicin—kidney cancer	5.28e-05	0.000202	CcSEcCtD
Doxazosin—Dyspnoea—Doxorubicin—kidney cancer	5.25e-05	0.0002	CcSEcCtD
Doxazosin—Somnolence—Doxorubicin—kidney cancer	5.23e-05	0.0002	CcSEcCtD
Doxazosin—Dyspepsia—Doxorubicin—kidney cancer	5.18e-05	0.000198	CcSEcCtD
Doxazosin—Decreased appetite—Doxorubicin—kidney cancer	5.12e-05	0.000195	CcSEcCtD
Doxazosin—Fatigue—Doxorubicin—kidney cancer	5.07e-05	0.000194	CcSEcCtD
Doxazosin—Constipation—Doxorubicin—kidney cancer	5.03e-05	0.000192	CcSEcCtD
Doxazosin—Pain—Doxorubicin—kidney cancer	5.03e-05	0.000192	CcSEcCtD
Doxazosin—Feeling abnormal—Doxorubicin—kidney cancer	4.85e-05	0.000185	CcSEcCtD
Doxazosin—Gastrointestinal pain—Doxorubicin—kidney cancer	4.81e-05	0.000184	CcSEcCtD
Doxazosin—Urticaria—Doxorubicin—kidney cancer	4.67e-05	0.000178	CcSEcCtD
Doxazosin—Body temperature increased—Doxorubicin—kidney cancer	4.65e-05	0.000178	CcSEcCtD
Doxazosin—Abdominal pain—Doxorubicin—kidney cancer	4.65e-05	0.000178	CcSEcCtD
Doxazosin—Hypersensitivity—Doxorubicin—kidney cancer	4.34e-05	0.000165	CcSEcCtD
Doxazosin—Asthenia—Doxorubicin—kidney cancer	4.22e-05	0.000161	CcSEcCtD
Doxazosin—Pruritus—Doxorubicin—kidney cancer	4.16e-05	0.000159	CcSEcCtD
Doxazosin—Diarrhoea—Doxorubicin—kidney cancer	4.03e-05	0.000154	CcSEcCtD
Doxazosin—Dizziness—Doxorubicin—kidney cancer	3.89e-05	0.000149	CcSEcCtD
Doxazosin—Vomiting—Doxorubicin—kidney cancer	3.74e-05	0.000143	CcSEcCtD
Doxazosin—Rash—Doxorubicin—kidney cancer	3.71e-05	0.000142	CcSEcCtD
Doxazosin—Dermatitis—Doxorubicin—kidney cancer	3.71e-05	0.000141	CcSEcCtD
Doxazosin—Headache—Doxorubicin—kidney cancer	3.69e-05	0.000141	CcSEcCtD
Doxazosin—Nausea—Doxorubicin—kidney cancer	3.5e-05	0.000133	CcSEcCtD
Doxazosin—ADRA2A—Metabolism—PSMD7—kidney cancer	5.55e-06	0.000413	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ITPR2—kidney cancer	5.54e-06	0.000412	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—RAF1—kidney cancer	5.53e-06	0.000412	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CA9—kidney cancer	5.46e-06	0.000407	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FLT1—kidney cancer	5.45e-06	0.000406	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CTNNA1—kidney cancer	5.41e-06	0.000402	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	5.4e-06	0.000402	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EIF4EBP1—kidney cancer	5.38e-06	0.0004	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HSPB1—kidney cancer	5.38e-06	0.0004	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—BCHE—kidney cancer	5.26e-06	0.000392	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—SLC5A5—kidney cancer	5.2e-06	0.000387	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—POMC—kidney cancer	5.14e-06	0.000382	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PAK1—kidney cancer	5.05e-06	0.000376	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—JUNB—kidney cancer	5.05e-06	0.000376	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CRABP1—kidney cancer	5.05e-06	0.000376	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CTNNA1—kidney cancer	5.02e-06	0.000374	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—SLC2A1—kidney cancer	5.02e-06	0.000374	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PSMD7—kidney cancer	5e-06	0.000372	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TSC1—kidney cancer	5e-06	0.000372	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ANXA1—kidney cancer	5e-06	0.000372	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EIF4EBP1—kidney cancer	4.99e-06	0.000372	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HSPB1—kidney cancer	4.99e-06	0.000372	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IGF2—kidney cancer	4.98e-06	0.00037	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	4.96e-06	0.00037	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—IL2—kidney cancer	4.96e-06	0.000369	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CDKN2B—kidney cancer	4.95e-06	0.000369	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CRABP1—kidney cancer	4.93e-06	0.000367	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FLT1—kidney cancer	4.84e-06	0.00036	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IGF1R—kidney cancer	4.81e-06	0.000358	CbGpPWpGaD
Doxazosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	4.8e-06	0.000357	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ITPR2—kidney cancer	4.69e-06	0.000349	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—POMC—kidney cancer	4.67e-06	0.000347	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CRABP1—kidney cancer	4.64e-06	0.000346	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PSMD7—kidney cancer	4.64e-06	0.000346	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TSC1—kidney cancer	4.64e-06	0.000346	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ANXA1—kidney cancer	4.64e-06	0.000346	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—RAF1—kidney cancer	4.63e-06	0.000345	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ITPR2—kidney cancer	4.58e-06	0.000341	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—IL2—kidney cancer	4.58e-06	0.000341	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—POMC—kidney cancer	4.56e-06	0.00034	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FLT1—kidney cancer	4.5e-06	0.000335	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PAK1—kidney cancer	4.49e-06	0.000334	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—JUNB—kidney cancer	4.49e-06	0.000334	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.33e-06	0.000322	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ITPR2—kidney cancer	4.32e-06	0.000321	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTT1—kidney cancer	4.28e-06	0.000319	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ACHE—kidney cancer	4.28e-06	0.000319	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—POMC—kidney cancer	4.24e-06	0.000316	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—VEGFA—kidney cancer	4.22e-06	0.000314	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GSTP1—kidney cancer	4.19e-06	0.000312	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTT1—kidney cancer	4.18e-06	0.000311	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—ACHE—kidney cancer	4.18e-06	0.000311	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PAK1—kidney cancer	4.17e-06	0.00031	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—JUNB—kidney cancer	4.17e-06	0.00031	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—IL2—kidney cancer	4.16e-06	0.000309	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—POMC—kidney cancer	4.14e-06	0.000309	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IGF2—kidney cancer	4.13e-06	0.000307	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CDKN2B—kidney cancer	4.11e-06	0.000306	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—SCARB1—kidney cancer	4.05e-06	0.000302	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS1—kidney cancer	4.01e-06	0.000299	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IGF1R—kidney cancer	3.99e-06	0.000297	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—MAPK3—kidney cancer	3.99e-06	0.000297	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—ABCB1—kidney cancer	3.96e-06	0.000295	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—HIF1A—kidney cancer	3.96e-06	0.000295	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—SCARB1—kidney cancer	3.96e-06	0.000294	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TSC2—kidney cancer	3.95e-06	0.000294	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ACHE—kidney cancer	3.94e-06	0.000293	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTT1—kidney cancer	3.94e-06	0.000293	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PSMD7—kidney cancer	3.93e-06	0.000293	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS1—kidney cancer	3.92e-06	0.000291	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—POMC—kidney cancer	3.85e-06	0.000287	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—GSTM1—kidney cancer	3.85e-06	0.000287	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—RAF1—kidney cancer	3.85e-06	0.000286	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PSMD7—kidney cancer	3.84e-06	0.000286	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—IL2—kidney cancer	3.8e-06	0.000283	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—MAPK1—kidney cancer	3.79e-06	0.000282	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—KDR—kidney cancer	3.79e-06	0.000282	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—BCHE—kidney cancer	3.73e-06	0.000278	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SCARB1—kidney cancer	3.73e-06	0.000277	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS1—kidney cancer	3.69e-06	0.000275	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—SLC5A5—kidney cancer	3.68e-06	0.000274	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF2—kidney cancer	3.67e-06	0.000273	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CDKN2B—kidney cancer	3.65e-06	0.000272	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CYP1A1—kidney cancer	3.65e-06	0.000272	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—BCHE—kidney cancer	3.64e-06	0.000271	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PSMD7—kidney cancer	3.62e-06	0.000269	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—SLC5A5—kidney cancer	3.6e-06	0.000268	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—KRAS—kidney cancer	3.58e-06	0.000267	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—SLC2A1—kidney cancer	3.56e-06	0.000265	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IGF1R—kidney cancer	3.55e-06	0.000264	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—APC—kidney cancer	3.49e-06	0.00026	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—KIT—kidney cancer	3.49e-06	0.00026	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—SLC2A1—kidney cancer	3.47e-06	0.000258	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.45e-06	0.000257	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL2—kidney cancer	3.45e-06	0.000257	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—BCHE—kidney cancer	3.43e-06	0.000255	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—RAF1—kidney cancer	3.42e-06	0.000254	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF2—kidney cancer	3.41e-06	0.000254	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CDKN2B—kidney cancer	3.39e-06	0.000253	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SLC5A5—kidney cancer	3.39e-06	0.000252	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—IL2—kidney cancer	3.37e-06	0.000251	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—MAPK3—kidney cancer	3.34e-06	0.000249	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—POMC—kidney cancer	3.32e-06	0.000247	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	3.31e-06	0.000247	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IGF1R—kidney cancer	3.29e-06	0.000245	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—PIK3CA—kidney cancer	3.29e-06	0.000245	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HIF1A—kidney cancer	3.29e-06	0.000245	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—BRAF—kidney cancer	3.28e-06	0.000244	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TSC2—kidney cancer	3.28e-06	0.000244	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SLC2A1—kidney cancer	3.27e-06	0.000244	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TP53—kidney cancer	3.19e-06	0.000237	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—MAPK1—kidney cancer	3.18e-06	0.000237	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—RAF1—kidney cancer	3.17e-06	0.000236	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KDR—kidney cancer	3.14e-06	0.000234	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—IL2—kidney cancer	3.13e-06	0.000233	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL2—kidney cancer	3.06e-06	0.000228	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—PIK3CA—kidney cancer	3.04e-06	0.000226	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.01e-06	0.000224	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—KRAS—kidney cancer	3e-06	0.000224	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTP1—kidney cancer	2.97e-06	0.000221	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HIF1A—kidney cancer	2.92e-06	0.000217	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TSC2—kidney cancer	2.91e-06	0.000217	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTP1—kidney cancer	2.9e-06	0.000216	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APC—kidney cancer	2.9e-06	0.000216	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KIT—kidney cancer	2.9e-06	0.000216	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL2—kidney cancer	2.85e-06	0.000212	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—ABCB1—kidney cancer	2.81e-06	0.000209	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KDR—kidney cancer	2.79e-06	0.000208	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—MAPK3—kidney cancer	2.77e-06	0.000206	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—PIK3CA—kidney cancer	2.76e-06	0.000205	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—POMC—kidney cancer	2.76e-06	0.000205	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RAF1—kidney cancer	2.74e-06	0.000204	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTP1—kidney cancer	2.73e-06	0.000203	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTM1—kidney cancer	2.73e-06	0.000203	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RELA—kidney cancer	2.73e-06	0.000203	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—BRAF—kidney cancer	2.72e-06	0.000203	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—POMC—kidney cancer	2.72e-06	0.000203	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HIF1A—kidney cancer	2.71e-06	0.000202	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ERBB2—kidney cancer	2.71e-06	0.000202	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TSC2—kidney cancer	2.71e-06	0.000201	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MTOR—kidney cancer	2.67e-06	0.000199	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTM1—kidney cancer	2.66e-06	0.000198	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—MAPK1—kidney cancer	2.64e-06	0.000196	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KDR—kidney cancer	2.59e-06	0.000193	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.58e-06	0.000192	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—ABCB1—kidney cancer	2.58e-06	0.000192	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KIT—kidney cancer	2.57e-06	0.000191	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APC—kidney cancer	2.57e-06	0.000191	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CYP1A1—kidney cancer	2.52e-06	0.000188	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—PIK3CA—kidney cancer	2.52e-06	0.000188	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CDKN1B—kidney cancer	2.51e-06	0.000187	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTM1—kidney cancer	2.51e-06	0.000187	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—KRAS—kidney cancer	2.49e-06	0.000186	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—MAPK3—kidney cancer	2.46e-06	0.000183	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL2—kidney cancer	2.46e-06	0.000183	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—POMC—kidney cancer	2.45e-06	0.000182	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—BRAF—kidney cancer	2.42e-06	0.00018	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CCND1—kidney cancer	2.39e-06	0.000178	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APC—kidney cancer	2.39e-06	0.000178	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KIT—kidney cancer	2.39e-06	0.000178	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—JUN—kidney cancer	2.39e-06	0.000178	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.38e-06	0.000177	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CTNNB1—kidney cancer	2.37e-06	0.000176	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—MAPK1—kidney cancer	2.34e-06	0.000174	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PTEN—kidney cancer	2.31e-06	0.000172	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PIK3CA—kidney cancer	2.29e-06	0.00017	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—MAPK3—kidney cancer	2.29e-06	0.00017	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—POMC—kidney cancer	2.27e-06	0.000169	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RAF1—kidney cancer	2.27e-06	0.000169	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RELA—kidney cancer	2.26e-06	0.000168	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ERBB2—kidney cancer	2.25e-06	0.000167	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—BRAF—kidney cancer	2.25e-06	0.000167	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—PIK3CA—kidney cancer	2.24e-06	0.000167	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MTOR—kidney cancer	2.22e-06	0.000165	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—KRAS—kidney cancer	2.21e-06	0.000165	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—MAPK1—kidney cancer	2.18e-06	0.000162	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTGS2—kidney cancer	2.17e-06	0.000162	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.12e-06	0.000158	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VEGFA—kidney cancer	2.09e-06	0.000155	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CDKN1B—kidney cancer	2.08e-06	0.000155	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PIK3CA—kidney cancer	2.08e-06	0.000155	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—KRAS—kidney cancer	2.06e-06	0.000153	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL2—kidney cancer	2.04e-06	0.000152	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	2.03e-06	0.000151	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RAF1—kidney cancer	2.02e-06	0.00015	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RELA—kidney cancer	2.01e-06	0.00015	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	2e-06	0.000149	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CCND1—kidney cancer	1.99e-06	0.000148	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—JUN—kidney cancer	1.98e-06	0.000148	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MAPK3—kidney cancer	1.97e-06	0.000147	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MTOR—kidney cancer	1.97e-06	0.000147	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CTNNB1—kidney cancer	1.97e-06	0.000146	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—POMC—kidney cancer	1.93e-06	0.000143	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MYC—kidney cancer	1.92e-06	0.000143	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PTEN—kidney cancer	1.92e-06	0.000143	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTEN—kidney cancer	1.89e-06	0.000141	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CA—kidney cancer	1.89e-06	0.000141	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—POMC—kidney cancer	1.88e-06	0.00014	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MAPK1—kidney cancer	1.88e-06	0.00014	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RAF1—kidney cancer	1.88e-06	0.00014	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RELA—kidney cancer	1.87e-06	0.000139	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ERBB2—kidney cancer	1.86e-06	0.000138	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	1.85e-06	0.000138	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MTOR—kidney cancer	1.83e-06	0.000136	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL2—kidney cancer	1.81e-06	0.000135	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—KRAS—kidney cancer	1.77e-06	0.000132	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—POMC—kidney cancer	1.77e-06	0.000132	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CCND1—kidney cancer	1.76e-06	0.000131	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—JUN—kidney cancer	1.76e-06	0.000131	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	1.75e-06	0.00013	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VEGFA—kidney cancer	1.73e-06	0.000129	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CDKN1B—kidney cancer	1.72e-06	0.000128	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PTEN—kidney cancer	1.7e-06	0.000127	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL2—kidney cancer	1.68e-06	0.000125	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CCND1—kidney cancer	1.64e-06	0.000122	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MAPK3—kidney cancer	1.64e-06	0.000122	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—JUN—kidney cancer	1.64e-06	0.000122	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CA—kidney cancer	1.63e-06	0.000121	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CTNNB1—kidney cancer	1.62e-06	0.000121	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MYC—kidney cancer	1.59e-06	0.000119	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTEN—kidney cancer	1.58e-06	0.000118	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TP53—kidney cancer	1.58e-06	0.000117	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MAPK1—kidney cancer	1.56e-06	0.000116	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	1.54e-06	0.000115	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS2—kidney cancer	1.54e-06	0.000114	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS2—kidney cancer	1.5e-06	0.000112	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KRAS—kidney cancer	1.47e-06	0.00011	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	1.46e-06	0.000108	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VEGFA—kidney cancer	1.43e-06	0.000106	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MYC—kidney cancer	1.42e-06	0.000105	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS2—kidney cancer	1.41e-06	0.000105	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	1.38e-06	0.000103	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CA—kidney cancer	1.35e-06	0.000101	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAPK3—kidney cancer	1.35e-06	0.000101	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTEN—kidney cancer	1.34e-06	9.98e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CA—kidney cancer	1.33e-06	9.94e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MYC—kidney cancer	1.31e-06	9.79e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTEN—kidney cancer	1.31e-06	9.74e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TP53—kidney cancer	1.31e-06	9.74e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KRAS—kidney cancer	1.31e-06	9.73e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MAPK1—kidney cancer	1.29e-06	9.58e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTEN—kidney cancer	1.23e-06	9.18e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KRAS—kidney cancer	1.21e-06	9.04e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	1.2e-06	8.94e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TP53—kidney cancer	1.16e-06	8.65e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CA—kidney cancer	1.12e-06	8.31e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TP53—kidney cancer	1.08e-06	8.04e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CA—kidney cancer	9.46e-07	7.04e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CA—kidney cancer	9.23e-07	6.87e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CA—kidney cancer	8.7e-07	6.48e-05	CbGpPWpGaD
